BSN.DEBSN.DEXETRA
Loading
EBITDA Over TimeExpanding
Percentile Rank100
3Y CAGR+20.3%
5Y CAGR+10.9%
Studio
Year-over-Year Change

Earnings before interest, taxes, depreciation, and amortization

3Y CAGR
+20.3%/yr
vs -1.5%/yr prior
5Y CAGR
+10.9%/yr
Recent acceleration
Acceleration
+21.8pp
Accelerating
Percentile
P100
Near historical high
vs 5Y Ago
1.7x
Solid growth
Streak
1 yr
Consecutive growthExpanding
PeriodValueYoY Change
TTM$7.40B+69.6%
2024$4.36B-8.1%
2023$4.75B+11.7%
2022$4.25B+2.6%
2021$4.15B-6.2%
2020$4.42B-13.3%
2019$5.09B+12.7%
2018$4.52B+1.9%
2017$4.44B+16.4%
2016$3.81B-